BACKGROUND: In recent years, many new conductive materials have provided a new direction for translational medicine treatment of myocardial infarction. OBJECTIVE: To classify and summarize conductive materials mentioned in the current literature, and review their research progress. METHODS: The key words were “biomaterial, nanomaterial, myocardial infarction, polypyrrole, polyaniline” in English and “biomaterials, myocardial infarction, heart tissue engineering” in Chinese. PubMed, Web of Science, Embase, CNKI, Wanfang, Vip and Chinese biomedical literature databases were retrieved for relevant literature published from 2015 to 2020. RESULTS AND CONCLUSION: Currently, in the field of myocardial infarction treatment, conductive biomaterials were divided into three categories: electroactive polymers (polypyrrole, polyaniline, polythiophene), carbon nanomaterials (grapheme and carbon nanotubes), and gold nanomaterials. These materials could be used in animal experiments to repair infarcted areas in the form of hydrogel or heart film patch. These materials, compared with traditional materials, had also shown better conductivity in vivo and in vitro experiments. The process of making materials, however, involved more multi-step synthesis reaction. Whether these materials could ensure low cytotoxicity and stability, there was no method or standard that could be accurately evaluated. At present, the conductive composites have only obtained promising effects in small animal myocardial infarction models. The safety and effectiveness of large animal models are still to be verified. [ABSTRACT FROM AUTHOR]